Search Results for 'AG-120'
-
Search Results
-
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin
ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.
https://clinicaltrials.gov/ct2/show/NCT02989857
Gavin